Hospital-at-Home Market Size, Share & Industry Analysis, By Service Type (Acute Medical & Physician Services, Skilled Nursing & Paramedic Services, Diagnostic & Therapeutic Services, and Rehabilitation & Support Services), By Age Group (Adults and Pediatric), By Component (Equipment, Devices & Accessories and Software & Services), By Indication (Respiratory, Cardiovascular, Infectious Diseases, and Gastrointestinal Conditions), By Service Provider (Hospitals & Health Systems, Specialized Hospital-at-Home Providers, and Home Healthcare & Community Care), and Regional Forecast, 2026-2034

The global hospital-at-home market size was valued at USD 7.80 billion in 2025. The market is projected to grow from USD 8.52 billion in 2026 to USD 17.07 billion by 2034, exhibiting a CAGR of 9.1% during the forecast period.

Hospital-at-home (HaH) refers to an acute clinical service care model that delivers active, inpatient-level hospital treatment inside a patient's home. The increasing prevalence of chronic diseases, growing government initiatives, an aging population, and rising healthcare expenditure are fueling adoption of these services in the market.  

• For instance, according to 2024 data published by the Centers for Disease Control & Prevention (CDC), about 1 in 20 adults were affected by coronary artery disease in the U.S.

Key players such as Amedisys and DispatchHealth Management, LLC are concentrating on offering novel services to boost their market positions.

Hospital-at-Home Market Trends

Growing Shift Toward Virtual and In-Person Acute Care Models is a Key Market Trend

There is an increasing shift toward hybrid acute-care models that integrate virtual clinical oversight and remote patient monitoring programs with scheduled in-person care at the patient’s residence. The advanced HaH models are designed to reproduce key elements of hospital-level care through a combination of physician consultations, digital health, nursing visits, medication administration, diagnostics, rehabilitation, and rapid escalation when a patient's condition deteriorates. Remote Patient Monitoring (RPM) platforms enable healthcare teams to continuously or periodically track parameters, including heart rate, blood pressure, oxygen saturation, temperature, and other condition-specific indicators without requiring clinicians to remain physically present in the home.

• For instance, according to 2023 data published by the Organization for Economic Co-operation and Development (OECD), approximately 2.8 teleconsultations were conducted per patient per year in Israel.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Aging Population is Driving Market Growth

The increasing aging population is expected to raise the prevalence of acute and chronic conditions, including musculoskeletal, cardiovascular, and other diseases. Many of these disorders can result in acute episodes requiring hospitalization, but after appropriate clinical assessment, selected patients can be treated safely through HaH programs.

• For instance, according to 2023 data published by the Government of China, about 297 million people were aged 60 and above in China.

This, coupled with increasing government initiatives supporting hospital-at-home programs, is fueling hospital-at-home market growth.

Market Restraints

Limited Nursing Staff to Hinder Market Growth

The limited availability of trained nursing professionals is hampering market growth. HaH programs involve patients who would otherwise require inpatient admission and therefore require a trained team capable of managing relatively high-acuity diseases outside the traditional environment. However, the limited availability of trained nursing staff is hampering facilities' ability to expand service capacity despite the growing demand for hospital-at-home services.

• For instance, according to the 2026 data published by the IOL, there are only 157,097 registered nurses in South Africa.

Market Opportunities

Expansion of Healthcare Infrastructure to Create Lucrative Opportunities

The expansion of healthcare infrastructure in developing nations presents a lucrative growth opportunity for the global market. There is a growing emphasis on private healthcare investment, trained nursing staff and other professionals, and expansion of insurance coverage in emerging countries, including Brazil, South Africa, and others. Increasing healthcare expenditure, coupled with growing adoption of telehealth and AI, is further contributing to increasing demand for these services in the market.

• According to 2024 data published by the International Trade Administration (ITA), it was reported that the healthcare expenditure was USD 135.0 billion in Brazil.

Market Challenges

Limited Healthcare Access in Emerging Countries to Limit Market Growth

The limited healthcare access across many lower-resource countries represents a key challenge to market expansion. Healthcare-at-home services require advanced healthcare infrastructure, trained nursing staff and physicians, reliable diagnostics, oxygen and infusion services, pharmacy and medication delivery, emergency transportation, remote patient monitoring, and rapid access to a physical hospital if the patient's condition deteriorates. Restricted accessibility of these capabilities across many emerging economies makes it difficult to identify suitable HaH patients. At the same time, shortages of physicians, nurses, paramedics, and diagnostic professionals further restrict the ability to provide frequent home visits.

• For instance, according to 2023 data published by The World Bank Group (WBG), approximately 4.5 billion people were not fully covered by essential health services globally.

SEGMENTATION ANALYSIS

By Service Type

Increasing Government Initiatives Led to Skilled Nursing & Paramedic Services Segment Dominance

Based on service type, the market is classified into acute medical & physician services, skilled nursing & paramedic services, diagnostic & therapeutic services, rehabilitation & support services, and others.

The skilled nursing & paramedic services segment held the largest share in 2025. The increasing prevalence of chronic conditions is driving demand for home healthcare services. This, along with growing government initiatives to promote skilled nursing facilities, is fueling segment growth.

• For instance, according to 2026 data, it was reported that the Centers for Medicare & Medicaid Services (CMS) awards incentive payments to skilled nursing facilities (SNFs) through the SNF VBP Program to encourage SNFs to improve the quality of care provided to patients.

The rehabilitation & support services segment is expected to grow at a CAGR of 9.4% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Age Group

Growing Disease Burden among Adults Led to Segment Dominance

Based on age group, the market is divided into adults and pediatric.

The adults segment dominated the global market in 2025. The increasing prevalence of chronic conditions among the adult population has resulted in a growing demand for home hospitalization, thereby contributing to the segmental growth in the market.

• For instance, according to the 2025 data published by the International Diabetes Federation (IDF), approximately 6.5 million adults were affected by diabetes in Germany.

The pediatric segment is set to rise at a CAGR of 11.1% over the forecast period.

By Component

Rising Need for Digital Platforms to Coordinate Hospital-level Care Boosted Software & Services Segment Growth

Based on component, the market is segmented into equipment, devices, & accessories and software & services.

The software & services segment dominated the global market in 2025. HaH programs depend on recurring clinical services and digital platforms to coordinate hospital-level care outside traditional facilities. Increasing adoption of software platforms in remote patient monitoring, clinical dashboards, alerts, virtual consultations, patient scheduling, EHR integration, and command-center operations is fueling segment growth.

The equipment, devices, & accessories segment is set to rise at a CAGR of 8.3% over the forecast period.

By Indication

Increasing Prevalence of Respiratory Conditions Led to Segment Dominance

Based on indication, the market is segmented into respiratory conditions, cardiovascular conditions, infectious diseases, gastrointestinal conditions, and others.

The respiratory conditions segment dominated the global hospital-at-home market share in 2025 due to the rising incidence of chronic conditions among patients. This, along with the growing adoption of technologically advanced devices for respiratory conditions, is propelling segment expansion.

• For instance, according to 2023 data published by the Centers for Disease Control & Prevention (CDC), the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease (COPD) in adults aged 18 and older was 3.8%, with women more likely to have COPD (4.1%) than men (3.4%)

The infectious diseases segment is set to rise at a CAGR of 8.8% over the forecast period.

By Service Provider

Increasing Number of Hospitals & Health Systems Led to Segment Dominance

Based on service provider, the market is divided into hospitals & health systems, specialized hospital-at-home providers, home healthcare & community care providers, and others.

The hospitals & health systems segment dominated the market in 2025. The increasing number of hospitals and growing nursing staff in hospitals are contributing to segment growth. Furthermore, the segment is set to hold a 61.2% share in 2026.

Home healthcare & community care providers are projected to grow at a 9.1% CAGR during the forecast period.

Hospital-at-Home Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Europe

To get more information on the regional analysis of this market, Download Free sample

Europe held the dominant share in 2024, valued at USD 3.91 billion, and also maintained its dominance in 2025 with USD 4.45 billion. The growing R&D activities for patient monitoring devices and value-based care are driving market growth.

U.K. Hospital-at-Home Market

The U.K. market in 2026 is estimated at around USD 0.12 billion, representing roughly 10.9% of global revenues.

Germany Hospital-at-Home Market

The market in Germany is projected to reach approximately USD 0.15 billion in 2026, equivalent to around 1.7% of global sales.

North America

North America is projected to record a CAGR of 10.6% in the coming years, which is the second highest among all regions, and reach a valuation of USD 1.68 billion in 2026. The increasing prevalence of chronic conditions and rapid adoption of hospital-at-home services are propelling market growth in the region.

• For instance, according to 2024 statistics published by the Centers for Medicare & Medicaid Services (CMS), healthcare expenditure was USD 5.3 trillion in the U.S.

U.S. Hospital-at-Home Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 1.42 billion in 2026, accounting for roughly 16.7% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 1.27 billion in 2026 and secure the position of the third-largest region in the market. The increasing healthcare expenditure is likely to support the growth of the market.

Japan Hospital-at-Home Market

The market in Japan in 2026 is estimated at around USD 0.07 billion, accounting for roughly 0.9% of global revenues.

China Hospital-at-Home Market

The market in China is projected to be one of the largest globally, with 2026 revenues estimated at around USD 0.29 billion, representing roughly 3.4% of global sales.

India Hospital-at-Home Market

The Indian market size in 2026 is estimated at around USD 0.08 billion, accounting for roughly 1.0% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 0.47 billion in 2026 due to the increasing adoption of digital tools and artificial intelligence for hospital-at-home services in the region. The Middle East & Africa market is expected to grow at a considerable rate due to the growing demand for acute care at home and advancements in virtual hospital care. In the Middle East & Africa, the GCC is set to reach a valuation of USD 0.14 billion in 2026.

South Africa Hospital-at-Home Market

The market in South Africa is projected to reach around USD 0.08 billion in 2026, representing roughly 0.9% of global revenues.

Competitive Landscape

Key Industry Players

Growing Key Players’ Focus on Strategic Partnerships to Support Their Dominance

Amedisys and DispatchHealth Management, LLC are major companies in the hospital-at-home market. A diversified services portfolio, along with a strong focus on strategic initiatives globally, is one of the major factors contributing to the dominance of these companies. Furthermore, the growing focus of key companies on collaborations with other companies is likely to strengthen their presence, further contributing to the global market share.

• For instance, in February 2021, Humana Inc., a health and well-being company, and DispatchHealth, a provider of in-home medical care, announced an agreement to provide Humana members with access to an advanced level of care in the home to help enhance patients’ experience and health outcomes.

List of Key Hospital-at-Home Companies Profiled

• DispatchHealth Management, LLC (U.S.)
• Amedisys (U.S.)
• Current Health, Inc. (U.K.)
• Biofourmis (U.S.)
• Doccla (U.K.)
• Cardinal Health (U.S.)
• Nobis LLC (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• GE Healthcare (U.S.)
• Masimo (U.S.)

KEY INDUSTRY DEVELOPMENTS

• June 2025: DispatchHealth merged with Medically Home to form the most comprehensive and established health care platforms focused on delivering complex care at home.
• November 2024: DispatchHealth received the Accreditation Commission for Health Care’s (ACHC) new In-Home Hospital Care Accreditation for its hospital-alternative care service.
• July 2024: Doccla partnered with the Health Service Executive (HSE) to introduce Virtual Wards in Ireland. This innovative collaboration aims to revolutionize patient care by enabling hospital-level treatment at home.
• May 2023: Atrium Health partnered with Best Buy Health to develop new hospital-at-home offerings to enhance the patient experience of receiving hospital-level care in the home.
• October 2021: Biofourmis, a company in digital therapeutics and virtual care that powers personalized predictive care, partnered with Integra Community Care Network, Care New England's accountable care organization (ACO), to strengthen its brand presence.

REPORT COVERAGE

The report provides a detailed global hospital-at-home market analysis and focuses on key aspects such as leading companies and market segmentation, including service type, age group, component, indication, and service provider. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope and Segmentation

Research Methodology

1. Bottom-Up Approaches

Approach 1:      Revenues and Market Share of Major HaH Players

• Collect HaH-attributable provider/operator revenue from annual reports, SEC filings, investor materials, company websites, and program disclosures.
• Analyze hospitals/health systems, specialized HaH providers, and community-care operators delivering qualifying acute care.
• Estimate undisclosed revenue from episodes, patient-days, program capacity, revenue/reimbursement per episode, and geographic footprint.
• Exclude routine home health, chronic RPM, hospice, routine home infusion, and non-HaH services.
• Triangulate company-level revenue with country-level demand and activity indicators.

Approach 2:   Country-Level HaH Spending and Demand Analysis

• Assess acute-care expenditure, admissions, bed utilization, avoidable admissions and early-discharge volumes.
• Evaluate HaH/virtual-ward capacity, patient volumes, reimbursement, public funding and payer coverage.
• Analyze demographic and epidemiological drivers for respiratory, cardiovascular, infectious, gastrointestinal, and other eligible acute conditions.
• Compare mature and emerging markets based on reimbursement maturity, infrastructure, and digital adoption.
• Estimate country HaH expenditure using eligible acute-care volumes, penetration, and revenue/reimbursement indicators.

Approach 3:   Bottom-Up Patient Episode and HaH Capacity Analysis

• Estimate acute admissions potentially eligible for HaH by country.
• Apply eligibility, home suitability, caregiver, acuity, and geographic-coverage assumptions.
• Estimate HaH episodes by admission avoidance and early supported discharge.
• Apply length-of-stay, patient-day, visit intensity and reimbursement per episode/day.
• Cross-check with available virtual-ward/HaH capacity, occupancy, and throughput.

2. Top Down Approaches

Approach 1:  Analysis of Parent Hospital and Healthcare Services Market

• Analysis of total national healthcare expenditure and hospital services expenditure as the primary addressable parent market for Hospital-at-Home.
• Identification of the proportion of hospital expenditure attributable specifically to acute inpatient and curative hospital care, using national health accounts, hospital financing statistics, inpatient expenditure, and reimbursement datasets.
• Exclusion of outpatient hospital services, emergency visits without admission, ambulatory/day-care procedures, conventional home healthcare, long-term care, hospice, and other non-Hospital-at-Home services.
• Estimation of the proportion of acute inpatient expenditure associated with HaH-eligible admissions and bed-days, considering respiratory, cardiovascular, infectious, gastrointestinal, and other qualifying acute conditions.
• Application of country-specific Hospital-at-Home penetration rates based on admission-avoidance activity, early supported discharge, virtual-ward/Hospital-in-the-Home capacity, patient volumes, and healthcare-system maturity.
• Adjustment for differences between conventional inpatient and HaH economics using DRG/case-based reimbursement, patient-day payments, bundled payments, global budgets, value-based arrangements, and reported HaH cost differentials.
• Application of country-specific inpatient utilization indicators including hospital admission rates, bed-day intensity, occupancy, average length of stay, hospital-bed availability, and public/private hospital participation.
• Comparison of Hospital-at-Home expenditure as a proportion of acute inpatient hospital expenditure across comparable countries to identify outliers and calibrate markets with incomplete data.
• Aggregation of country-level top-down estimates to derive regional and global Hospital-at-Home market values.
• Comparison of the top-down estimate with provider/operator revenues, HaH patient episodes, patient-day/capacity models, reimbursement-per-episode models, and country-level bottom-up estimates before finalizing the market size.

3. List of Key Sources

• CMS/HHS, NHS England, French DREES, Spain Ministry of Health, Victoria Department of Health and other national health authorities.
• FDA, MHRA, European Commission/MDR/EUDAMED, PMDA, NMPA, CDSCO, TGA and national provider regulators.
• WHO, OECD, Eurostat, World Bank and national health expenditure databases.
• Annual reports, SEC filings, investor presentations, company websites, program reports and clinical case studies.
• Peer-reviewed clinical studies, systematic reviews, health-economic studies and patient-outcome evidence.

4. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
• HaH provider executives and commercial leaders
• Hospital/health-system HaH program directors
• RPM and virtual-care platform executives
• Medical device, mobile diagnostics, pharmacy, infusion, and logistics suppliers
• Home nursing/community paramedicine operations leaders
• Demand Side Interviews: 40%
• Key respondents:
• Hospital CMOs, COOs, CFOs and service-line leaders
• Hospitalists, acute-care nurses, pharmacists and care coordinators
• Public health-system purchasers and integrated care boards
• Payer medical directors and value-based care leaders
• Procurement, IT, cybersecurity and interoperability teams